

Centre for Oncology and Immunology Fifth Symposium
Immunotherapy for Cancer Treatment: Breakthroughs and Innovations
28 February 2025 (Friday), 9:00 AM - 6:00 PM
Grand Hall, Hong Kong Science and Technology Park
Welcome to COI's 5th Symposium, "Immunotherapy for Cancer Treatment: Breakthroughs and Innovations", an event that will bring together leading scientists and industry experts to discuss the latest advancements in cancer immunotherapy. This symposium will showcase groundbreaking research and innovative approaches aimed at harnessing the power of the immune system to combat cancer. Our symposium features stimulating presentations and thought-provoking panel discussions that will provide valuable insights into the future of cancer treatment. Don't miss this opportunity to engage with top professionals from around the world, exchange ideas, and foster collaborations.
_edited.png)
Speakers

Prof. Mark Davis
Director
Stanford Institute for Immunity, Transplantation and Infection, Stanford University
Professor
Microbiology and Immunology,
Stanford University

Prof. Hai Qi 祁海教授
Executive Vice-Chancellor
School of Medicine, Tsinghua University
Professor
School of Medicine, Tsinghua University

Prof. Qiang Pan-Hammarström
Professor
Department of Medical Biochemistry and Biophysics, Karolinska Institutet

Prof. Stephen Schoenberger
Professor
La Jolla Institute for Immunology

Prof. Jürgen Ruland
Professor
Director, Institute for Clinical Chemistry and Pathobiochemistry, Technical University of Munich

Prof. Naoto Hirano
Senior Scientist
Chair, Immuno-Oncology Program
Princess Margaret Cancer Centre, University Health Network
Professor
Department of Immunology, University of Toronto
Associate Director for Research
Tumor Immunotherapy Program, Princess Margaret Cancer Centre

Prof. Liwei Lu
Project Leader
Centre for Oncology and Immunology Ltd.
Professor (Immunology)
Department of Pathology, The University of Hong Kong

Prof. Carmen Wong
Programme Leader
Centre for Oncology and Immunology Ltd.
Associate Professor
Department of Pathology, The University of Hong Kong

Prof. Tak Mak
Co-Director (Scientific)
Centre for Oncology and Immunology Ltd.
Professor
Department of Medical Biophysics and Immunology, University of Toronto
Senior Scientist
Princess Margaret Cancer Centre, University Health Network
Honorary Professor
Department of Pathology, The University of Hong Kong
.png)
Prof. Lisa Butterfield
Distinguished Scientist
Merck

Prof. Tracy McGaha
Senior Scientist
Princess Margaret Cancer Centre, University Health Network
Professor
Department of Immunology, University of Toronto

Prof. Aya El Helali
Clinical Assistant Professor
Department of Clinical Medicine, The University of Hong Kong
Agenda
8:30AM - 9:10AM
Registration
9:10AM - 9:15AM
Welcome Remarks
Albert Wong |
Chief Executive Officer, Hong Kong Science and Technology Parks Corporation
9:15AM - 9:20AM
Opening Remarks
Tak Mak, Ph.D. |
Co-Director, Centre for Oncology and Immunology
9:20AM - 9:30AM
Group Photo
Session 1
Highlight Session 1
9:30AM - 10:25AM
GZMK-expressing CD8 T cells in chronic inflammatory diseases
Hai Qi, Ph.D |
Professor, Tsinghua University
10:25AM - 10:55AM
Break and Networking / Poster Session 1
Panel Discussion 1
11:50AM - 12:20PM
Future Directions and Challenges in Cancer Immunotherapy
Panel moderators: Prof. Tracy McGaha & Prof. Carmen Wong
Hai Qi, Ph.D |
Professor, Tsinghua University
Stephen Schoenberger, Ph.D. |
Professor, La Jolla Institute for Immunology
Liwei Lu, Ph.D. |
Project Leader, Centre for Oncology and Immunology Ltd.
Aya El Helali, MB BCh, MRCP, Ph.D. |
Clinical Assistant Professor, The University of Hong Kong
Highlight Session 2
10:55AM - 11:50AM
The spontaneous neoantigen-specific CD4+ T cell response to a growing tumor is functionally and phenotypically diverse
Stephen Schoenberger, Ph.D. |
Professor, La Jolla Institute for Immunology
12:20PM - 2:00PM
Lunch and Networking / Poster Session 2
Session 2
Highlight Session 3
2:00PM - 2:55PM
Cancer Vaccines, Individualized Therapies and Immune Biomarkers
Lisa Butterfield, Ph.D. |
Distinguished Scientist, Merck
Highlight Session 4
2:55PM - 3:45PM
Infections, immunity and B cell lymphomagenesis
Qiang Pan-Hammarström, M.D., Ph.D. |
Professor, Karolinska Institutet
3:45PM - 4:15PM
Break and Networking / Poster Session 3
Panel Discussion 2
5:10PM - 5:40PM
Translating Immunotherapy Research into Clinical Applications
Panel moderators: Prof. Tak Mak & Prof. Naoto Hirano
Mark Davis, Ph.D. |
Professor, Stanford University
Qiang Pan-Hammarström, M.D., Ph.D. |
Professor, Karolinska Institutet
Lisa Butterfield, Ph.D. |
Distinguished Scientist, Merck
Jürgen Ruland, Ph.D. |
Professor, Technical University of Munich
Highlight Session 5
4:15PM - 5:10PM
Immune organoids to advance our understanding of autoimmunity, infection and vaccination in human beings
Mark Davis, Ph.D. |
Professor, Stanford University
5:40PM - 5:45PM
Closing Remarks
Suet-Yi Leung, M.D. |
Co-Director, Centre for Oncology and Immunology
Co-organized by

Supported by



In Collaboration with


Platinum Sponsor

Gold Sponsors












Silver Sponsor

© 2025 by Centre for Oncology and Immunology